slotkoers
Korea S.E.
00:00:00 24-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.150
KRW
|
-4,23%
|
|
-11,70%
|
+0,94%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
197.110
|
124.311
|
172.971
|
239.297
|
112.271
|
68.746
|
Bedrijfswaarde
1 |
223.685
|
145.168
|
204.069
|
232.510
|
132.911
|
56.129
|
K/w-verhouding
|
-11,4
x
|
-4,33
x
|
-6,16
x
|
-10,6
x
|
-4,45
x
|
8,55
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,29
x
|
1,71
x
|
2,15
x
|
2,37
x
|
1,12
x
|
3,77
x
|
Bedrijfswaarde/omzet
|
2,6
x
|
1,99
x
|
2,54
x
|
2,3
x
|
1,32
x
|
3,08
x
|
Bedrijfswaarde/EBITDA
|
-163
x
|
-11,1
x
|
-33,6
x
|
-29,6
x
|
-16,9
x
|
54,5
x
|
Bedrijfswaarde/FCF
|
-11,4
x
|
-7,76
x
|
-5,9
x
|
-38,2
x
|
-15,9
x
|
4,25
x
|
FCF Yield
|
-8,77%
|
-12,9%
|
-16,9%
|
-2,62%
|
-6,3%
|
23,5%
|
Price to Book
|
8,39
x
|
5,22
x
|
5,65
x
|
5,42
x
|
5,25
x
|
2,08
x
|
Aantal aandelen (in duizenden)
|
15.960
|
17.683
|
27.412
|
28.658
|
31.449
|
32.275
|
Referentieprijs
2 |
12.350
|
7.030
|
6.310
|
8.350
|
3.570
|
2.130
|
Datum van publicatie
|
15-03-19
|
18-03-20
|
19-03-21
|
23-03-22
|
23-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
86.067
|
72.877
|
80.453
|
101.170
|
100.413
|
18.245
|
EBITDA
1 |
-1.370
|
-13.113
|
-6.065
|
-7.850
|
-7.857
|
1.031
|
Bedrijfsresultaat (EBIT)
1 |
-5.557
|
-18.075
|
-11.958
|
-14.651
|
-14.591
|
-5.164
|
Operationele Marge
|
-6,46%
|
-24,8%
|
-14,86%
|
-14,48%
|
-14,53%
|
-28,3%
|
Resultaat voor belastingen (EBT)
1 |
-16.542
|
-41.308
|
-31.691
|
-36.736
|
-34.990
|
-6.139
|
Nettowinst (verlies)
1 |
-17.228
|
-28.046
|
-21.138
|
-19.768
|
-23.137
|
8.009
|
Nettomarge
|
-20,02%
|
-38,48%
|
-26,27%
|
-19,54%
|
-23,04%
|
43,9%
|
WPA
2 |
-1.081
|
-1.622
|
-1.024
|
-790,2
|
-802,1
|
249,0
|
Free Cash Flow
1 |
-19.607
|
-18.713
|
-34.587
|
-6.094
|
-8.373
|
13.211
|
FCF-marge
|
-22,78%
|
-25,68%
|
-42,99%
|
-6,02%
|
-8,34%
|
72,41%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
1.281,98%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
164,96%
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
15-03-19
|
18-03-20
|
19-03-21
|
23-03-22
|
23-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
26.575
|
20.857
|
31.098
|
-
|
20.639
|
-
|
Nettokaspositie
1 |
-
|
-
|
-
|
6.787
|
-
|
12.617
|
Hefboom (schuld/ebitda)
|
-19,4
x
|
-1,591
x
|
-5,128
x
|
-
|
-2,627
x
|
-
|
Free Cash Flow
1 |
-19.607
|
-18.713
|
-34.587
|
-6.094
|
-8.373
|
13.211
|
ROE (netto-inkomsten/eigen vermogen)
|
-31,3%
|
-65,3%
|
-44%
|
-37,3%
|
-40,7%
|
-11,9%
|
ROA (netto-inkomsten/totale activa)
|
-3,64%
|
-7,5%
|
-4,41%
|
-4,83%
|
-5,41%
|
-3,27%
|
Totale activa
1 |
473.371
|
374.134
|
479.129
|
409.666
|
427.858
|
-245.040
|
Nettoactief per aandeel
2 |
1.472
|
1.347
|
1.116
|
1.541
|
680,0
|
1.022
|
Cashflow per aandeel
2 |
2.400
|
2.459
|
1.395
|
2.063
|
386,0
|
587,0
|
Capex
1 |
4.061
|
23.502
|
17.783
|
1.767
|
1.717
|
339
|
Capex/omzet
|
4,72%
|
32,25%
|
22,1%
|
1,75%
|
1,71%
|
1,86%
|
Datum van publicatie
|
15-03-19
|
18-03-20
|
19-03-21
|
23-03-22
|
23-03-23
|
20-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +0,94% | 59,43 mln. | | +38,51% | 727 mld. | | +33,05% | 599 mld. | | -6,23% | 354 mld. | | +18,78% | 328 mld. | | +1,35% | 277 mld. | | +16,00% | 243 mld. | | +8,09% | 205 mld. | | -5,77% | 203 mld. | | +6,19% | 164 mld. |
Farmaceutische producten - Andere
|